Paid Clinical Trials in Macon, GA
As of August 2026, 70 paid clinical trials are recruiting in Macon, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Macon offers studies at sites including Atrium Health Navicent for conditions such as Atopic Dermatitis, Graves' Disease, Idiopathic Hypersomnia, Narcolepsy Type 1. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Macon
Trials by drug in Macon
Filter results
Newly added in Macon
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
67 clinical trials
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Top Research Study Locations in Macon
Researchers run research studies in Macon, GA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Atrium Health Navicent | B Acute Lymphoblastic Leukemia, Adrenal Gland Pheochromocytoma, Anaplastic Kidney Wilms Tumor | 12 |
| Gastroenterology Associates of Central Georgia | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 7 |
| Alkermes Investigational Site | Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia | 4 |
| Sleep Practitioners, LLC | Narcolepsy, Cataplexy, EDS | 3 |
| The Jones Center Clinical Research | Obesity, Overweight, Atherosclerotic Cardiovascular Disease | 3 |
| Atrium Health Navicent The Medical Center | Open tíbia Fracture, Osteomyelitis Tibia, Persistent Atrial Fibrillation | 2 |
| Central Georgia Cancer Care | Breast Neoplasms, Neoplasm Metastasis, Squamous Cell Carcinoma of Head and Neck | 2 |
| GSK Investigational Site | HIV Infections, Multiple Myeloma | 2 |
| Gastroenterolgy Associates of Central GA | Colitis, Ulcerative, Crohn Disease | 2 |
| Gastroenterology Associates of Central Georgia, LLC | Bowel; Stricture, Esophageal Stricture | 2 |
| Skin Care Physicians Of Georgia | Alopecia Areata, Alopecia, Areata Alopecia | 2 |
| Skin Care Physicians of Georgia - Macon | Pruritus, Atopic Dermatitis | 2 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Central Georgia Cancer Care - Macon | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Central Georgia Cancer Care PC | Extensive Stage Small-cell Lung Cancer, Small-cell Lung Cancer | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| East Coast Institute For Research LLC | Kidney Disease, Chronic | 1 |
| East Coast Institute for Research | Type 1 Diabetes Mellitus With Hypoglycemia | 1 |
| Gastroenterology Associates of Central GA | Crohn Disease | 1 |
| Georgia Memory Net Memory Assessment Clinic - Macon | Alzheimer Disease | 1 |
| Hemlock Ambulatory Surgery Center | Lumbar Spinal Stenosis | 1 |
| Leo Pharma Investigational site | Atopic Dermatitis | 1 |
| Mercer University, Department of Internal Medicine | HIV-1-infection | 1 |
| Mercer university, Department of internal medicine-Clinical Research | Human Immunodeficiency Virus Type 1 (HIV-1) Infection | 1 |
Active & Upcoming Studies in Macon (2026)
Recruiting trials in Macon grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (14 active studies)
- A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM) · Phase 2 · GlaxoSmithKline
- Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 · Phase 3 · AstraZeneca
Diabetes & metabolic (5 active studies)
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes · Phase 3 · Eli Lilly and Company
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
Cardiovascular (4 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
HIV / STI (3 active studies)
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 · Phase 2 · Gilead Sciences
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · ViiV Healthcare
Neurology & pain (1 active study)
- Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry · Emory University
Common conditions studied in Macon
- Atopic Dermatitis (3 active studies)
- Graves' Disease (3 active studies)
- Idiopathic Hypersomnia (3 active studies)
- Narcolepsy Type 1 (3 active studies)
- B Acute Lymphoblastic Leukemia (2 active studies)
- Crohn Disease (2 active studies)
Leading research sponsors in Macon
- Children's Oncology Group
- Alkermes, Inc.
- Wake Forest University Health Sciences
- AstraZeneca
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Macon?
There are approximately 70 recruiting clinical trials in Macon, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Macon pay participants?
Most recruiting trials in Macon compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Macon?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Macon?
The most common conditions under active study in Macon include Atopic Dermatitis (3), Graves' Disease (3), Idiopathic Hypersomnia (3), Narcolepsy Type 1 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Macon?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Macon on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Macon?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Macon?
Recruiting research sites in Macon include Atrium Health Navicent, Gastroenterology Associates of Central Georgia, Alkermes Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Macon right now?
The largest active categories in Macon are Cancer & tumors (14), Diabetes & metabolic (5), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.